Arbutus Biopharma Corporation (ABUS)

NASDAQ: ABUS · IEX Real-Time Price · USD

3.130

+0.010 (0.32%)

At close: Jul 2, 2024, 4:00 PM

3.140

+0.010 (0.32%)

After-hours: Jul 2, 2024, 6:03 PM EDT

Arbutus Biopharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2008
Net Income	-72.85	-69.46	-88.39	-75.87	-164.87	Upgrade
Depreciation & Amortization	1.4	1.43	1.75	1.98	2.03	Upgrade
Share-Based Compensation	9.3	7.18	6.42	6.16	6.8	Upgrade
Other Operating Activities	-23.79	25.49	0.54	4.17	73.89	Upgrade
Operating Cash Flow	-85.94	-35.36	-67.53	-51.44	-71.01	Upgrade
Capital Expenditures	-0.99	-0.51	-0.81	-0.23	-0.58	Upgrade
Acquisitions	0	0	0	-2.5	0	Upgrade
Change in Investments	51.76	-74.43	-11.87	-12.18	28.92	Upgrade
Investing Cash Flow	50.77	-74.94	-12.68	-14.91	28.34	Upgrade
Share Issuance / Repurchase	30.65	31.81	137.24	86.75	18.91	Upgrade
Other Financing Activities	-	-	-	-	18.55	Upgrade
Financing Cash Flow	30.65	31.81	137.24	86.75	37.46	Upgrade
Exchange Rate Effect	0.03	-0.02	0.01	0.06	0.07	Upgrade
Net Cash Flow	-4.49	-78.51	57.03	20.45	-5.14	Upgrade
Free Cash Flow	-86.92	-35.87	-68.34	-51.67	-71.58	Upgrade
Free Cash Flow Margin	-479.16%	-91.92%	-621.96%	-747.32%	-1190.88%	Upgrade
Free Cash Flow Per Share	-0.52	-0.24	-0.64	-0.68	-1.25	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).